Biotech

Ocugen’s COVID-19 co-vaccine development partner, Bharat Biotech, shares second interim results that include 100% protection against serious diseases, including hospitalization

British biotech firm’s 750 mn GM mosquitoes will mate with females outside Florida and sow a deadly gene

3 Biotech shares with big catalysts around the corner

Global Medicine of Prostate Cancer Surgery 2021 Opportunities, Challenges, Key Actors, Predisposition to 2031 | AstraZeneca plc, Active Biotech, Bristol Myers-Squibb

Ocugen stocks rise after candidate Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy

Ocugen’s COVID-19 co-vaccine development partner, Bharat Biotech, shares Phase 3 COVAXIN interim results, shows 81% efficiency Nasdaq: OCGN

Ocugen’s COVID-19 co-vaccine development partner, Bharat Biotech, shares Phase 3 COVAXIN Interim Results, Shows 81% Efficiency

India asks Bharat Biotech to submit efficacy data from Covaxin’s ongoing Phase 3 trials

Brazil buys 20 million COVID-19 vaccines from Bharat Biotech in India

Biotech suitable for the Red Planet

Indian state rejects Bharat Biotech vaccine approved without efficacy data

China Approves Sinovac Biotech COVID-19 Vaccine for General Use